Co-Delivery of Doxorubicin and Schisandrin B by Liposome to Overcome Multidrug Resistance

Tian-ao LI,Jian-miao YANG,Dong-hang XU,Jian-qing GAO

DOI: https://doi.org/10.11669/cpj.2017.20.012

2017-01-01

Abstract:OBJECTIVE To investigate the synergetic effect of schisandrin B and liposomes on overcoming multidrug resistance (MDR).METHODS Co-delivery of doxorubicin and schisandrin B by liposome(DS-L) were prepared,and doxorubicin solution(FDOX),schisandrin B and doxorubicin mixture(Sch B + DOX),doxorubicin liposomes(D-L),doxorubicin liposomes and schisandrin B mixture(D-L + Sch B),verapamil and doxorubicin mixture (Ver + DOX) were also prepared as the control.The MTT test were measured,and the amount of doxorubicin in the K562/DOX cells at different time were determined,and time course of uptake and eiflux were drawn.RESULTS The MTT test shows that the resistance factor(RF) of group DS-L were 1.68,14.52 and 1.42 times of group Sch B + DOX,group D-L and group D-L + Sch B respectively.The uptake test shows that amount of doxorubicin of K562/DOX cells in group DSL was 1.30 and 1.21 times of that in group D-L and group Sch B + DOX respectively.And the efflux test shows DS-L could delay doxorubicin efflux from K562/DOX cells.CONCLUSION The co-delivery of chemotherapeutics and P-gp inhibitors schisandrin B by liposome is a promising approach to overcome MDR.And there is a synergistic effect between liposome and schisandrin B to overcome MDR.